Articles tagged "Living donor"

2020 American Transplant Congress
Opioid Prescription Pattern and Risk Factors Associated with Opioid Use after Living Donor Hepatectomy in the US
M. Nguyen¹, L. Vest², Z. Zhang², V. Whittaker³, M. Schnitzler¹, D. Axelrod⁴, H. Randall¹, C. Varma¹, J. Snyder⁵, B. Kasiske⁵, D. Segev⁶, M. McAdams Demarco⁷, G. Hess⁸, K. Lentine²
¹Department of Surgery, Saint Louis University, Saint Louis, MO, ²Department of Medicine, Saint Louis University, Saint Louis, MO, ³Department of Surgery, New York Medical College, New York, NY, ⁴Department of Surgery, University of Iowa, Iowa City, IA, ⁵SRTR, Minneapolis, MN, ⁶Department of Surgery, Johns Hopkins University, Baltimore, MD, ⁷Johns Hopkins University, Baltimore, MD, ⁸Drexel University, Philadelphia, PA
*Purpose: Opioids are the cornerstone of acute pain management after living donor hepatectomy. Their misuse poses the danger of chronic abuse. How this affects living…
2020 American Transplant Congress
Geographical Disparities in Transplantation: Exploring the Association between County Health Rankings and an Individual’s Access to Transplantation
A. J. Carter, R. D. Reed, D. Hendricks, K. N. Baldwin, A. C. Kale, J. E. Locke
Surgery, University of Alabama at Birmingham, Birmingham, AL
*Purpose: Since 2004, living kidney donation has declined, with the southeastern United States disproportionately affected. Programs such as the Living Donor Navigator (LDN), designed to…
2020 American Transplant Congress
Validation of the Graft Volume Formula Avoiding Small-for-Size Graft Dysfunction in Adult to Adult Living Donor Liver Transplantation
A. Nishimagi, N. Sato, Y. Kofunato, T. Ishigame, R. Okada, T. Kimura, A. Kenjo, S. Marubashi
Department of Hepato-Biliary-Pancreatic and Transplant Surgery, Fukishima Medical University, Fukushima, Japan
*Purpose: It is important to determine the optimal volume of liver graft in living donor liver transplantation(LDLT) for avoiding small-for-size graft syndrome(SFSS) A formula of…
2020 American Transplant Congress
Optimal Perioperative Management of Patients Undergoing Living Donor Nephrectomy Reduces Postoperative Length of Stay and Nausea and Vomiting
R. Chadha¹, S. Aniskevich¹, D. Perry², C. Taner², J. Burns²
¹Anesthesiology and Perioperative Medicine, Mayo Clinic Florida, Jacksonville, FL, ²Transplant Surgery, Mayo Clinic Florida, Jacksonville, FL
*Purpose: Renal transplantation with organs from living donors saves thousands of lives every year. In the perioperative period, poorly controlled nausea and pain can prolong…
2020 American Transplant Congress
The Impact of Non-Directed Anonymous Live Liver Donors on the Number of Children on the Waitlist at a Single Pediatric Liver Transplant Center
D. Yoeli¹, M. A. Adams¹, M. E. Wachs¹, S. S. Sundaram², R. A. Choudhury¹, K. D. Conzen¹, J. R. Burton³, E. A. Pomfret¹, W. E. Jackson³
¹Transplant Surgery, University of Colorado, Aurora, CO, ²Pediatric Hepatology, University of Colorado, Aurora, CO, ³Transplant Hepatology, University of Colorado, Aurora, CO
*Purpose: Since the initiation of our living donor (LD) pediatric liver transplant program in November 2016, 10 non-directed anonymous donors have been approved and completed…
2020 American Transplant Congress
Improving Value Delivery in Living Donor Kidney Transplant Through Process Improvement
S. Anand, J. Browning, W. Stapley, M. Egbert, J. Krong, J. Zobell, A. Herbert, S. Dow, L. Dong, D. Morris, T. Srinivas
Intermountain Medical Center, Murray, UT
*Purpose: To increase living donation through process improvement.*Methods: Quality improvement project, with intention to substantially improve the living donor (LD) transplant (Tx) rate. Participants: All…
2020 American Transplant Congress
Can a Patient with Von Willebrand Disease Donate a Kidney?
Y. Marie¹, W. McKane¹, R. Maclean², R. Pararajasingam¹
¹Renal Transplantation, Sheffield Kidney Institute, Sheffield, United Kingdom, ²Haematology, Sheffield Teaching Hospitals, Sheffield, United Kingdom
*Purpose: Von Willebrand disease (VWD) is a haematological condition that can be challenging to deal with during any operative intervention. We report a successful example…
2020 American Transplant Congress
Cancer Risk in Living Kidney Donors (LKDs) in the United States
E. Engels¹, K. Yu¹, S. Brown¹, K. Pawlish², C. Lynch³, B. Kasiske⁴, J. Snyder⁴, R. Pfeiffer¹
¹National Cancer Institute, Bethesda, MD, ²New Jersey Dept of Health, Trenton, NJ, ³Univ of Iowa, Iowa City, IA, ⁴Scientific Registry of Transplant Recipients, Minneapolis, MN
*Purpose: Individuals who wish to donate a kidney for transplantation are evaluated for transmissible diseases (including cancer) prior to donation. Outcomes in LKDs after donation…
2020 American Transplant Congress
Evolution of Molecular MMDx Scores after Kidney Transplantationin Different Donor Categories
P. Hruba¹, K. S. Madill-Thomsen², M. Mackova², J. Maluskova³, E. Honsova³, J. Slatinska⁴, P. F. Halloran², O. Viklicky⁴
¹Transplant Laboratory, IKEM, Prague, Czech Republic, ²ATAGC, University of Alberta, Edmonton, AB, Canada, ³Department of Pathology, IKEM, Prague, Czech Republic, ⁴Department of Nephrology, IKEM, Prague, Czech Republic
*Purpose: The outcome of kidney transplantation is highly affected by donor category. Little is known about molecular processes which may underline this phenomenon.*Methods: Using Molecular…
2020 American Transplant Congress
Transient Elastography to Evaluate Steatosis in Candidate Living Donors for Liver Transplantation
E. Palte¹, J. Duong², H. Remotti³, J. Burt³, A. Griesemer⁴, B. Samstein⁵, D. Marratta⁶, A. N. Fox⁷
¹Columbia University Vagelos College of Physicians and Surgeons, New York, NY, ²Columbia University Mailman School of Public Health, New York, NY, ³Department of Pathology and Cell Biology, Columbia University, New York, NY, ⁴Department of Surgery, Columbia University, New York, NY, ⁵Department of Surgery, Weill Cornell Medicine, New York, NY, ⁶Department of Medicine, Columbia University, New York, NY, ⁷Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY
*Purpose: Living donor liver transplantation (LDLT) increases the donor pool and affords a life-saving cure to recipients who do not have MELD-based access to allografts.…